Streetbeat News

Stock Prices

COCO

Vita Coco has increased its FY23 net sales growth outlook from 10%-12% to approximately 13%-15%. The company has also reaffirmed its gross margin guidance at 35%-37%.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 11:04 am

AMGN

Amgen reported Q3 earnings of $4.96 per share, beating the analyst consensus estimate of $4.66 by 6.44%. However, the company's quarterly sales of $6.90 billion missed the analyst consensus estimate of $6.94 billion by 0.59%. This represents a 5.53% increase in earnings and a 3.77% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 11:04 am

DORM

Dorman Products has reduced its FY23 revenue forecast from $1.95 billion - $2 billion to $1.925 billion - $1.945 billion, which is below the estimated $1.96 billion.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 11:03 am

MBUU

Malibu Boats (NASDAQ:MBUU) reported Q1 adjusted earnings of $1.13 per share, beating the analyst consensus estimate of $0.88 by 28.41%. However, this is a 36.87% decrease from the same period last year. The company also reported quarterly sales of $255.83 million, surpassing the analyst consensus estimate of $244.13 million by 4.79%, but this is a 15.35% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 11:03 am

DORM

Dorman Prods (NASDAQ:DORM) reported Q3 adjusted earnings of $1.40 per share, missing the analyst consensus estimate of $1.60 by 12.5%. However, the company's quarterly sales of $488.20 million beat the estimate of $487.26 million by 0.19%. The earnings and sales figures represent a 19.66% and 18.07% increase respectively from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 11:01 am

BLD

TopBuild has increased its FY23 sales outlook to between $5.13B and $5.21B, up from the previous estimate of $5.025B-$5.175B. The company also expects its adjusted EBITDA to be between $1.025B and $1.055B.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 11:00 am

NPO

Enpro has revised its FY23 guidance, expecting adjusted EBITDA and adjusted EPS to be toward the lower end of its previous guidance of $248M-$256M and $6.70-$7.10, respectively. The consensus was $6.93.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 10:57 am

XYL

Xylem (NYSE:XYL) reported Q3 earnings of $0.99 per share, beating the analyst consensus estimate of $0.89 by 11.24%. This is a 13.79% increase from the same period last year. The company also reported quarterly sales of $2.08 billion, beating the analyst consensus estimate of $1.99 billion by 4.32%. This is a 50.43% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 10:56 am

PFE

Pfizer has reported a 41% operational decrease in Q3 FY23 revenues, attributing the decline to expected lower revenues from Paxlovid and Comirnaty.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 10:54 am

PFE

Pfizer has reaffirmed its FY23 guidance, which was provided in October, of revenues between $58B-$61B and an adjusted EPS of $1.45-$1.65. The consensus estimates were $59.82B for revenues and $1.59 for EPS.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 10:53 am